Clinical Trial Update: Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate

View source ↗

Summary

A completed clinical trial analyzing blood biomarkers in patients with refractory non-small cell lung cancer who were previously treated with sorafenib tosylate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Nexavar (sorafenib tosylate) (sorafenib tosylate)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Lung Cancer | Status: COMPLETED